145 related articles for article (PubMed ID: 37517472)
1. Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors: The AIM BRAIN Project: An Australian and New Zealand Children's Haematology/Oncology Group Study.
White CL; Kinross KM; Moore MK; Rasouli E; Strong R; Jones JM; Cain JE; Sturm D; Sahm F; Jones DTW; Pfister SM; Robertson T; D'Arcy C; Rodriguez ML; Dyke JM; Junckerstorff R; Bhuva DD; Davis MJ; Wood P; Hassall T; Ziegler DS; Kellie S; McCowage G; Alvaro F; Kirby M; Heath JA; Tsui K; Dodgshun A; Eisenstat DD; Khuong-Quang DA; Wall M; Algar EM; Gottardo NG; Hansford JR
J Mol Diagn; 2023 Oct; 25(10):709-728. PubMed ID: 37517472
[TBL] [Abstract][Full Text] [Related]
2. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care.
Karimi S; Zuccato JA; Mamatjan Y; Mansouri S; Suppiah S; Nassiri F; Diamandis P; Munoz DG; Aldape KD; Zadeh G
Clin Epigenetics; 2019 Dec; 11(1):185. PubMed ID: 31806041
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study.
Pickles JC; Fairchild AR; Stone TJ; Brownlee L; Merve A; Yasin SA; Avery A; Ahmed SW; Ogunbiyi O; Gonzalez Zapata J; Peary AF; Edwards M; Wilkhu L; Dryden C; Ladon D; Kristiansen M; Rowe C; Kurian KM; Nicoll JAR; Mitchell C; Bloom T; Hilton DA; Al-Sarraj S; Doey L; Johns PN; Bridges LR; Chakrabarty A; Ismail A; Rathi N; Syed K; Lammie GA; Limback-Stanic C; Smith C; Torgersen A; Rae F; Hill RM; Clifford SC; Grabovska Y; Williamson D; Clarke M; Jones C; Capper D; Sill M; von Deimling A; Pfister SM; Jones DTW; Hargrave D; Chalker J; Jacques TS
Lancet Child Adolesc Health; 2020 Feb; 4(2):121-130. PubMed ID: 31786093
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation profiling improves routine diagnosis of paediatric central nervous system tumours: A prospective population-based study.
Schepke E; Löfgren M; Pietsch T; Olsson Bontell T; Kling T; Wenger A; Ferreyra Vega S; Danielsson A; Dosa S; Holm S; Öberg A; Nyman P; Eliasson-Hofvander M; Sandström PE; Pfister SM; Lannering B; Sabel M; Carén H
Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12838. PubMed ID: 35892159
[TBL] [Abstract][Full Text] [Related]
5. Decoding the DNA methylome of central nervous system tumors: An emerging modality for integrated diagnosis.
Satomi K; Ichimura K; Shibahara J
Pathol Int; 2024 Feb; 74(2):51-67. PubMed ID: 38224248
[TBL] [Abstract][Full Text] [Related]
6. Validation of Whole Genome Methylation Profiling Classifier for Central Nervous System Tumors.
Santana-Santos L; Kam KL; Dittmann D; De Vito S; McCord M; Jamshidi P; Fowler H; Wang X; Aalsburg AM; Brat DJ; Horbinski C; Jennings LJ
J Mol Diagn; 2022 Aug; 24(8):924-934. PubMed ID: 35605901
[TBL] [Abstract][Full Text] [Related]
7. Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics.
Wu Z; Abdullaev Z; Pratt D; Chung HJ; Skarshaug S; Zgonc V; Perry C; Pack S; Saidkhodjaeva L; Nagaraj S; Tyagi M; Gangalapudi V; Valdez K; Turakulov R; Xi L; Raffeld M; Papanicolau-Sengos A; O'Donnell K; Newford M; Gilbert MR; Sahm F; Suwala AK; von Deimling A; Mamatjan Y; Karimi S; Nassiri F; Zadeh G; Ruppin E; Quezado M; Aldape K
Neuro Oncol; 2022 Apr; 24(4):571-581. PubMed ID: 34555175
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation provides diagnostic value for meningioma recurrence in clinical practice.
Shen E; Leclair NK; Herlth K; Soucy M; Renzette N; Zhuo X; Kelly K; Omerza G; Onyiuke H; McNeill I; Wolansky L; Becker K; Li L; Wu Q; Bulsara KR
Acta Neurochir (Wien); 2023 May; 165(5):1323-1331. PubMed ID: 36920663
[TBL] [Abstract][Full Text] [Related]
9. Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience.
Capper D; Stichel D; Sahm F; Jones DTW; Schrimpf D; Sill M; Schmid S; Hovestadt V; Reuss DE; Koelsche C; Reinhardt A; Wefers AK; Huang K; Sievers P; Ebrahimi A; Schöler A; Teichmann D; Koch A; Hänggi D; Unterberg A; Platten M; Wick W; Witt O; Milde T; Korshunov A; Pfister SM; von Deimling A
Acta Neuropathol; 2018 Aug; 136(2):181-210. PubMed ID: 29967940
[TBL] [Abstract][Full Text] [Related]
10. Microarray-Based DNA Methylation Profiling: Validation Considerations for Clinical Testing.
Leung ML; Abdullaev Z; Santana-Santos L; Skaugen JM; Moore S; Ji J
J Mol Diagn; 2024 Jun; 26(6):447-455. PubMed ID: 38378079
[TBL] [Abstract][Full Text] [Related]
11. Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas.
Otani Y; Satomi K; Suruga Y; Ishida J; Fujii K; Ichimura K; Date I
Brain Tumor Pathol; 2023 Apr; 40(2):56-65. PubMed ID: 37004583
[TBL] [Abstract][Full Text] [Related]
12. Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impact.
Drexler R; Brembach F; Sauvigny J; Ricklefs FL; Eckhardt A; Bode H; Gempt J; Lamszus K; Westphal M; Schüller U; Mohme M
Acta Neuropathol Commun; 2024 Jan; 12(1):9. PubMed ID: 38229158
[TBL] [Abstract][Full Text] [Related]
13. Sarcoma classification by DNA methylation profiling in clinical everyday life: the Charité experience.
Roohani S; Ehret F; Perez E; Capper D; Jarosch A; Flörcken A; Märdian S; Zips D; Kaul D
Clin Epigenetics; 2022 Nov; 14(1):149. PubMed ID: 36380356
[TBL] [Abstract][Full Text] [Related]
14. DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker.
Azizgolshani N; Petersen CL; Chen Y; Levy JJ; Salas LA; Perreard L; Nguyen LN; Christensen BC
Clin Epigenetics; 2021 Sep; 13(1):176. PubMed ID: 34538273
[TBL] [Abstract][Full Text] [Related]
15. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
[No Abstract] [Full Text] [Related]
16. The Implementation of DNA Methylation Profiling into a Multistep Diagnostic Process in Pediatric Neuropathology: A 2-Year Real-World Experience by the French Neuropathology Network.
Pages M; Uro-Coste E; Colin C; Meyronet D; Gauchotte G; Maurage CA; Rousseau A; Godfraind C; Mokhtari K; Silva K; Figarella-Branger D; Varlet P; On Behalf Of The Renoclip-Loc Network
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33803647
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncology.
Pratt D; Sahm F; Aldape K
Neuro Oncol; 2021 Nov; 23(23 Suppl 5):S16-S29. PubMed ID: 34725697
[TBL] [Abstract][Full Text] [Related]
18. Methylation-based algorithms for diagnosis: experience from neuro-oncology.
Pickles JC; Stone TJ; Jacques TS
J Pathol; 2020 Apr; 250(5):510-517. PubMed ID: 32057098
[TBL] [Abstract][Full Text] [Related]
19. Genome-Wide DNA Methylation Profiling as Frontline Diagnostics for Central Nervous System Embryonal Tumors in Hong Kong.
Tam OCH; Ho RSL; Chan S; Li KKW; Lam TL; Cheung ETY; Cheung OY; Ho WWS; Cheng KKF; Shing MMK; Ku DTL; Chung BHY; Yang W; Chan GCF; Ng HK; Liu APY
Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835574
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing.
Galbraith K; Vasudevaraja V; Serrano J; Shen G; Tran I; Abdallat N; Wen M; Patel S; Movahed-Ezazi M; Faustin A; Spino-Keeton M; Roberts LG; Maloku E; Drexler SA; Liechty BL; Pisapia D; Krasnozhen-Ratush O; Rosenblum M; Shroff S; Boué DR; Davidson C; Mao Q; Suchi M; North P; Hopp A; Segura A; Jarzembowski JA; Parsons L; Johnson MD; Mobley B; Samore W; McGuone D; Gopal PP; Canoll PD; Horbinski C; Fullmer JM; Farooqui MS; Gokden M; Wadhwani NR; Richardson TE; Umphlett M; Tsankova NM; DeWitt JC; Sen C; Placantonakis DG; Pacione D; Wisoff JH; Teresa Hidalgo E; Harter D; William CM; Cordova C; Kurz SC; Barbaro M; Orringer DA; Karajannis MA; Sulman EP; Gardner SL; Zagzag D; Tsirigos A; Allen JC; Golfinos JG; Snuderl M
Neurooncol Adv; 2023; 5(1):vdad076. PubMed ID: 37476329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
